We are live on ! Find out more
JGP Global Gestao de Recursos

JGP Global Gestao de Recursos Portfolio holdings

AUM $49.2M Turnover 48.72%
1-Year Est. Return 27.21%
This Fund
S&P 500
This Quarter Est. Return
+14.19%
1 Year Est. Return
+27.21%
3 Year Est. Return
+260.74%
5 Year Est. Return
+528.28%
10 Year Est. Return
+850.85%
AUM
$49.2M
AUM Growth
+$3.85M
Cap. Flow
-$717K
Cap. Flow %
-1.46%
Top 10 Hldgs %
90.29%
Holding
39
New
5
Increased
14
Reduced
–
Closed
14
Avg Time Held Equity + Options
2.2 years
Top 10 Avg Time Held Equity + Options
0.3 years
Top 20 Avg Time Held Equity + Options
0.8 years
Avg Time Held Equity only
2.3 years
Top 10 Avg Time Held Equity only
0.3 years
Top 20 Avg Time Held Equity only
0.8 years

Top Buys

Rank Stock Value
1
IAUX icon
i-80 Gold Corp
IAUX
+$9.6M
2
XP icon
XP
XP
+$401K
3
NVDA icon
NVIDIA
NVDA
+$322K
4
LRCX icon
Lam Research
LRCX
+$246K
5
ASML icon
ASML
ASML
+$234K

Top Sells

Rank Stock Value
1
VEON icon
VEON
VEON
+$3.49M
2
ATAI icon
AtaiBeckley Inc
ATAI
+$2.64M
3
ECHO icon
EchoStar
ECHO
+$2.2M
4
ITUB icon
Itaú Unibanco
ITUB
+$1.37M
5
STM icon
STMicroelectronics
STM
+$401K

Sector Composition

Rank Sector Weight
1 Miscellaneous 32.81%
2 Financials 29.02%
3 Materials 20.25%
4 Healthcare 16.17%
5 Technology 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
XP icon
1
XP
XP
$15.5B
$14.3M 29.02%
679,766
+22,547
+3% +$401K
2025 Q1
6 quarters
IAUX icon
2
i-80 Gold Corp
IAUX
$1.3B
$10M 20.25%
+6,000,000
New +$9.6M
2026 Q3
0 quarters
SPY icon
3
State Street SPDR S&P 500 ETF Trust
SPY
$826B
$7.85M 15.96%
10,290
– –
2026 Q2
1 quarter
LLY icon
4
Eli Lilly
LLY
$1.13T
$1.31M 2.66%
1,130
+32
+3% +$37.8K
2018 Q4
31 quarters
NVDA icon
5
PUT
NVIDIA
NVDA
$5.35T
$906K 1.84%
6,000
+3,000
+100% +$643K
2026 Q2
1 quarter
ABBV icon
6
AbbVie
ABBV
$501B
$773K 1.57%
2,955
+84
+3% +$21.5K
2025 Q1
6 quarters
INCY icon
7
Incyte
INCY
$23B
$682K 1.39%
5,620
– –
2021 Q1
22 quarters
JNJ icon
8
Johnson & Johnson
JNJ
$617B
$645K 1.31%
2,437
+69
+3% +$18.2K
2025 Q1
6 quarters
ONC icon
9
BeOne Medicines Ltd
ONC
$43.9B
$626K 1.27%
1,711
– –
2018 Q4
31 quarters
MRK icon
10
Merck
MRK
$367B
$504K 1.03%
3,470
+98
+3% +$13.5K
2026 Q2
1 quarter
UNH icon
11
UnitedHealth
UNH
$375B
$469K 0.95%
1,279
+36
+3% +$14.5K
2026 Q2
1 quarter
BMY icon
12
Bristol-Myers Squibb
BMY
$124B
$395K 0.8%
6,333
+179
+3% +$11.3K
2025 Q1
6 quarters
VRTX icon
13
Vertex Pharmaceuticals
VRTX
$133B
$390K 0.79%
746
+21
+3% +$10.8K
2018 Q4
31 quarters
TMO icon
14
Thermo Fisher Scientific
TMO
$257B
$371K 0.75%
549
+15
+3% +$8.91K
2021 Q2
21 quarters
RVMD icon
15
Revolution Medicines
RVMD
$42B
$365K 0.74%
1,778
– –
2026 Q2
1 quarter
KOD icon
16
Kodiak Sciences
KOD
$5.63B
$347K 0.7%
+3,656
New +$151K
2026 Q3
0 quarters
NVDA icon
17
NVIDIA
NVDA
$5.35T
$343K 0.7%
+1,504
New +$322K
2026 Q3
0 quarters
GILD icon
18
Gilead Sciences
GILD
$190B
$328K 0.67%
2,200
+62
+3% +$8.7K
2025 Q1
6 quarters
ABT icon
19
Abbott
ABT
$171B
$292K 0.59%
2,957
+83
+3% +$8.67K
2025 Q1
6 quarters
LRCX icon
20
Lam Research
LRCX
$329B
$259K 0.53%
+787
New +$246K
2026 Q3
0 quarters
ASML icon
21
ASML
ASML
$647B
$245K 0.5%
+135
New +$234K
2026 Q3
0 quarters
ISRG icon
22
Intuitive Surgical
ISRG
$152B
$237K 0.48%
583
+17
+3% +$6.49K
2019 Q1
30 quarters
MDGL icon
23
Madrigal Pharmaceuticals
MDGL
$10.8B
$218K 0.44%
433
– –
2023 Q4
11 quarters
OIBR.C
24
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$13.1K 0.03%
50,301
– –
2025 Q4
3 quarters
ACAD icon
25
Acadia Pharmaceuticals
ACAD
$3.47B
– –
-8,110
Closed -$205K –
1
2

Similar funds

Altai Capital Management
Altai Capital Management West Hollywood, California $49M AUM 4.84% 1-Year Est. Return
Jones Road Capital Management
Jones Road Capital Management New York $49M AUM 17.65% 1-Year Est. Return
Lattice Capital Management
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
Index Venture Associates III
Index Venture Associates III St. Helier, Channel Islands, Jersey $48.8M AUM
Goodwin Investment Advisory
Goodwin Investment Advisory Woodstock, Georgia $49.7M AUM 16.61% 1-Year Est. Return
Glaxis Capital Management
Glaxis Capital Management Sarasota, Florida $49.8M AUM 23.19% 1-Year Est. Return
SIP Global Opportunity Manager
SIP Global Opportunity Manager Portsmouth, New Hampshire $48.5M AUM
FTB
First Trust Bank Nassau, Bahamas $49.8M AUM 26.11% 1-Year Est. Return

JGP Global Gestao de Recursos's Q3 2026 Portfolio in Review

As of Q3 2026, JGP Global Gestao de Recursos held 39 positions worth $49.2M, up 8.5% from $45.3M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

JGP Global Gestao de Recursos's Q3 2026 filing shows 5 new, 14 increased and 14 closed positions. Its largest new stake was i-80 Gold Corp: 6,000,000 shares worth $10M. The largest sale was VEON, an estimated $3.49M.

By sector, the portfolio is most concentrated in Miscellaneous at 33% of assets, down from 37% a quarter earlier, followed by Financials and Materials.

  • JGP Global Gestao de Recursos's largest Q3 2026 buy was i-80 Gold Corp: 6,000,000 shares worth $10M.
  • JGP Global Gestao de Recursos added most to XP in Q3 2026, an estimated $401K increase.
  • JGP Global Gestao de Recursos fully exited VEON in Q3 2026, selling an estimated $3.49M.
  • JGP Global Gestao de Recursos's ten largest holdings make up 90% of its $49.2M portfolio in Q3 2026.
  • JGP Global Gestao de Recursos opened 5 new positions and closed 14 in Q3 2026.
  • JGP Global Gestao de Recursos's portfolio value rose 8.5% quarter-over-quarter to $49.2M.

Based on JGP Global Gestao de Recursos's 13F filing for Q3 2026, filed 16 Oct 2026.